Beschreibung
⋅ KAVL has had a strong fall down to a long-term demand zone. High risk play but big bounce potential.
Kommentar
⋅ 400m before the FDA shenanigans. 40M expected afterwards.
Price drop from $5 to $0.50.
FDA shenanigans reversed.
$5 inc Kommentar
⋅ Boom
Kommentar
⋅ Bout time for another bounce. Hard floor at 10 cents.